The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN)

BACKGROUND: We aimed to explore whether erenumab, a monoclonal antibody targeting the calcitonin gene-related peptide receptor, could exert a central effect on brain network function in migraine, and investigate the persistence of such an effect following treatment discontinuation. METHODS: This was...

Descripción completa

Detalles Bibliográficos
Autores principales: Filippi, Massimo, Messina, Roberta, Bartezaghi, Marta, Cetta, Ilaria, Colombo, Bruno, Grazzi, Licia, Martinelli, Daniele, Ornello, Raffaele, Pichiecchio, Anna, Raimondi, Debora, Russo, Antonio, Sacco, Simona, Splendiani, Alessandra, Tassorelli, Cristina, Turrini, Renato, Valsasina, Paola, Rocca, Maria Assunta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576673/
https://www.ncbi.nlm.nih.gov/pubmed/37550498
http://dx.doi.org/10.1007/s00415-023-11879-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576673/
https://www.ncbi.nlm.nih.gov/pubmed/37550498
http://dx.doi.org/10.1007/s00415-023-11879-9

Ejemplares similares